ZeroStack (7300) Stock Overview
Through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
7300 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
ZeroStack Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$5.65 |
| 52 Week High | US$45.40 |
| 52 Week Low | US$4.86 |
| Beta | 2.01 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -58.13% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -85.51% |
Recent News & Updates
Recent updates
Shareholder Returns
| 7300 | DE Personal Products | DE Market | |
|---|---|---|---|
| 7D | 0% | 1.2% | 2.9% |
| 1Y | -58.1% | -7.0% | 12.1% |
Return vs Industry: 7300 underperformed the German Personal Products industry which returned -6% over the past year.
Return vs Market: 7300 underperformed the German Market which returned 11.4% over the past year.
Price Volatility
| 7300 volatility | |
|---|---|
| 7300 Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 5.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in DE Market | 13.8% |
| 10% least volatile stocks in DE Market | 2.7% |
Stable Share Price: 7300's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: Insufficient data to determine 7300's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | 21 | Daniel Reis-Faria | zerostack.ai |
ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. It operates through Commercial & Wholesale and Digital Assets segments. The company distributes a range of pharmaceutical goods and medical products to treat various health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants.
ZeroStack Corp. Fundamentals Summary
| 7300 fundamental statistics | |
|---|---|
| Market cap | €10.21m |
| Earnings (TTM) | -€98.53m |
| Revenue (TTM) | €30.46m |
Is 7300 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7300 income statement (TTM) | |
|---|---|
| Revenue | US$35.68m |
| Cost of Revenue | US$34.03m |
| Gross Profit | US$1.65m |
| Other Expenses | US$117.06m |
| Earnings | -US$115.41m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -47.48 |
| Gross Margin | 4.62% |
| Net Profit Margin | -323.49% |
| Debt/Equity Ratio | 75.8% |
How did 7300 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/10 11:39 |
| End of Day Share Price | 2026/01/29 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
ZeroStack Corp. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Rommel Dionisio | Aegis Capital Corporation |
| William Kirk | Roth Capital Partners |